Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-०.२१%
१,०९१.५१
-२.३०
-०.२१%
१,०९३.८११,०९६.५२१,१००.२२१,०९१.५१
SIXC
Communications
SIXC
Communications
SIXC
+०.२२%
६१०.११
+१.३४
+०.२२%
६०८.७७६०८.७७६१२.९७६०८.७७
SIXE
Energy
SIXE
Energy
SIXE
-१.३४%
१,२३७.९८
-१६.८३
-१.३४%
१,२५४.८११,२५३.०११,२५३.८७१,२२६.३३
SIXI
Industrials
SIXI
Industrials
SIXI
-०.९३%
१,७४४.७१
-१६.४०
-०.९३%
१,७६१.१११,७६४.२७१,७६६.८८१,७४४.७१
SIXM
Financials
SIXM
Financials
SIXM
-०.३७%
६४०.१८
-२.४०
-०.३७%
६४२.५८६४४.८७६४८.४८६४०.१८
SIXR
Staples
SIXR
Staples
SIXR
-०.१८%
८४९.५८
-१.५५
-०.१८%
८५१.१३८५५.६६८५८.७५८४५.५६
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-०.२३%
२१७.४८
-०.५०
-०.२३%
२१७.९८२१७.९८२१८.६५२१६.८८
SIXT
Technology
SIXT
Technology
SIXT
+१.५२%
३,२६०.६९
+४८.८६
+१.५२%
३,२११.८३३,२२७.२१३,२६८.३८३,२२६.५५
SIXU
Utilities
SIXU
Utilities
SIXU
-०.६९%
९४२.४५
-६.५३
-०.६९%
९४८.९८९४८.५८९५७.८३९४१.९७
SIXV
Health care
SIXV
Health care
SIXV
-०.५२%
१,४६६.८०
-७.७२
-०.५२%
१,४७४.५२१,४७९.०३१,४८१.०४१,४६६.८०
SIXY
Discretionary
SIXY
Discretionary
SIXY
+०.२२%
२,३९७.५०
+५.३८
+०.२२%
२,३९२.१२२,३९६.९५२,४२१.२२२,३८२.३२
NVS:BCBA
Novartis CEDEAR
ARS १०,८००.००
०.००%
(०.००) 1D
अप्रिल १९, १६:४०:३६ GMT-३  ·   ARS
All symbols
SymbolPriceChange% Change
Generating top insights for NVS...
Mkt. cap
२.९६ खरब
Volume
०.००
Shares outstanding
२.०३ अरब
No. of employees
७५ हजार
News stories
From sources across the web
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes. After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis CEDEAR
CEOVasant Narasimhan
Employees७५.३ हजार
Founded१९९६ फेब्रुअरी २९
Headquartersबेसेल, Basel City, स्विट्जरल्यान्ड
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
१४.८४ अरब
१४.३६ अरब
१३.८६ अरब
१३.५२ अरब
Cost of goods sold
३.३२ अरब
३.५४ अरब
३.५४ अरब
३.४४ अरब
Cost of revenue
३.३२ अरब
३.५४ अरब
३.५४ अरब
३.४४ अरब
Research and development expenses
२.६२ अरब
२.८६ अरब
२.८४ अरब
२.७८ अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३.४४ अरब
३.३० अरब
३.४४ अरब
३.१४ अरब
Operating expense
६.०५ अरब
६.२४ अरब
६.४६ अरब
५.९६ अरब
Total operating expenses
९.३७ अरब
९.७७ अरब
१०.०० अरब
९.४० अरब
Operating income
५.४६ अरब
४.५८ अरब
३.८६ अरब
४.१२ अरब
Other non operating income
-१.३० करोड
-७०.०० लाख
-१३.०० करोड
४०.०० लाख
EBT including unusual items
४.५३ अरब
४.२० अरब
३.२२ अरब
३.८४ अरब
EBT excluding unusual items
५.१६ अरब
४.२९ अरब
३.४९ अरब
३.७८ अरब
Income tax expense
५०.७० करोड
२६.६० करोड
८१.४० करोड
६८.३० करोड
Effective tax rate
११.१९%
६.३४%
२५.३०%
१७.७९%
Other operating expenses
-४०.०० लाख
७.०० करोड
१९.०० करोड
४.२० करोड
Net income
४.०४ अरब
३.९३ अरब
२.४१ अरब
३.१६ अरब
Net profit margin
२७.२४%
२७.३६%
१७.३८%
२३.३४%
Earnings per share
२.४२
२.२५
२.०३
१.९९
Interest and investment income
-
-
३७.३० करोड
-
Interest expense
-२८.९० करोड
-२८.१० करोड
-३०.४० करोड
-३४.३० करोड
Net interest expenses
-२८.९० करोड
-२८.१० करोड
६.९० करोड
-३४.३० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
६.५६ अरब
५.७८ अरब
४.९६ अरब
५.२४ अरब
Gain or loss from assets sale
-६.७० करोड
८.१० करोड
८.०० करोड
-१५.९० करोड
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more